Recital 3, Regulation (EU) 2022/112

In forcesince 25 Jan 2022

In vitro diagnostic medical devices are essential to the health and safety of Union citizens, and SARS-CoV-2 tests, in particular, are vital in the fight against the pandemic. Therefore, it is necessary to ensure that there is an uninterrupted market supply of such devices in the Union.